Sequana Medical NV (SEQUA.BR) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · Belgium · ISIN BE0974340722
Sequana Medical NV financials
| Fiscal year | 2023 | 2024 |
|---|---|---|
| Revenue | 712,173.00 EUR | 106,000.00 EUR |
| Gross profit | 548,049.00 EUR | -2.22 m EUR |
| Operating income | -29.49 m EUR | -18.71 m EUR |
| EBIT | -29.49 m EUR | -18.01 m EUR |
| Net income | -32.56 m EUR | -44.65 m EUR |
| Diluted EPS – continuing operations | -1.22 EUR | -1.22 EUR |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sequana Medical NV
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.
More stocks
- ES SUNLOGY BERHAD (0345.KL)
- JKG Land Bhd (6769.KL)
- WFE Technology Corporation (6474.TWO)
- RenovoRx, Inc. (RNXT)
- H.H.Galaxy Co., Ltd. (2949.TWO)
- Seresco S.A. (SCO.MC)
- FreeCast, Inc. Class A Common Stock (CAST)
- Millie Seojae. (418470.KQ)
- FLYEXCLUSIVE INC. (FLYX)
- Bekasi Fajar Industrial Estate (BEST.JK)
- Hotel Holiday Garden (2702.TW)
- CITIZENS HOLDING CO /MS/ (CIZN)
Not investment advice. All data without warranty, price as of 28.04.2026. Details in the risk notice.